iRepertoire is working with iCubate, our sister company in the Hudson Alpha Institute, to develop innovative solutions for combating the Coronavirus.
On one side of the intervention strategy, iCubate is distributing diagnostic tests based on the same technology that powers the iR-Flex automation system.
On the other side, iRepertoire will be sequencing the immune repertoire of patients whose immune systems effectively combat the disease. Identifying the clonal populations that expand and protect infected patients could help with the development of more effective treatments for the disease.
iRepertoire scientist Miranda Byrne-Steele explained the effort in an interview by WAFF48 news. Watch it here!